FDA pulls Covid antibody treatment because it’s not effective against dominant omicron variants
The FDA said bebtelovimab is no longer authorized for use because it is not expected to neutralize the omicron BQ.1
Read MoreThe FDA said bebtelovimab is no longer authorized for use because it is not expected to neutralize the omicron BQ.1
Read More"We've got a public health problem coming at our door, these trends have been increasing for a long time now,"
Read MoreFlu has hit unusually hard and early this season, putting pressure on emergency departments across the nation. Source link
Read MoreThe White House, in a statement, said the Chinese people have the right to protest peacefully. Source link
Read MoreThe study did not look at hospitalization, but experts believe the omicron booster shots will provide strong protection against severe
Read MoreThe BQ coronavirus subvariants are likely resistant to key antibody medications used by people with compromised immune systems. Source link
Read MoreWalmart, Target, Gap, Kohl's and others are trying to sell through a glut of extra merchandise piling up in store
Read MoreSeniors and children younger than age 5 are most at risk right now, public health official said. Source link
Read MoreModerna also missed revenue and earnings expectations for the quarter. Source link
Read More